Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Tuberculosis

Free Subscription Articles published in Lancet Retrieve available abstracts of 35 articles: HTML format

Single Articles

December 2025
1. HUI D, Sahu S, Ditiu L, Marais BJ, et al
   Global tuberculosis response off track: urgent priorities to end the world's top infectious killer.
   Lancet. 2025 Dec 11:S0140-6736(25)02433-X. doi: 10.1016/S0140-6736(25)02433.
   PubMed    
   
   
   
2. LATEEF S
   Aid cuts hampering Nepal's tuberculosis care.
   Lancet. 2025 Dec 4:S0140-6736(25)02469-9. doi: 10.1016/S0140-6736(25)02469.
   PubMed    
   
   
   August 2025
3. DROBNIEWSKI F, Kon OM, Gonzalo X, Ashmi M, et al
   Why are we failing to rapidly diagnose tuberculosis in the UK?
   Lancet. 2025;406:908-909.
   PubMed    
   
   
   July 2025
4. MACIEL EL, Pablos-Mendez A, Abubakar I
   Undoing progress through sudden tuberculosis funding cuts.
   Lancet. 2025 Jul 3:S0140-6736(25)01328-5. doi: 10.1016/S0140-6736(25)01328.
   PubMed    
   
   
   
5. HALLETT TB, Menzies NA, Resch S, Pretorius C, et al
   The case for optimal investment in combating HIV, tuberculosis, and malaria: a global modelling study.
   Lancet. 2025 Jul 3:S0140-6736(25)00831-1. doi: 10.1016/S0140-6736(25)00831.
   PubMed     Abstract available
   
   
   June 2025
6. AL ZAMEL AM, Saeed AA, Elmubarak M, Alsarraj MA, et al
   Sudan's tuberculosis response needs global support amid conflict.
   Lancet. 2025 Jun 2:S0140-6736(25)01119-5. doi: 10.1016/S0140-6736(25)01119.
   PubMed    
   
   
   April 2025
7. KLUGE HHP
   Tuberculosis: a threat to health security in the European region and the collective actions needed.
   Lancet. 2025 Apr 7:S0140-6736(25)00677-4. doi: 10.1016/S0140-6736(25)00677.
   PubMed    
   
   
   March 2025
8. DHEDA K, Perumal T, Fox GJ
   Asymptomatic tuberculosis: undetected and underestimated, but not unimportant.
   Lancet. 2025 Mar 21:S0140-6736(25)00555-0. doi: 10.1016/S0140-6736(25)00555.
   PubMed    
   
   
   
9. JERENE D, van Kalmthout K, Levy J, Alacapa J, et al
   Effect of digital adherence technologies on treatment outcomes in people with drug-susceptible tuberculosis: four pragmatic, cluster-randomised trials.
   Lancet. 2025 Mar 11:S0140-6736(24)02847-2. doi: 10.1016/S0140-6736(24)02847.
   PubMed     Abstract available
   
   
   
10. MARX FM, Civan A
    Rethinking the benefits of digital adherence technologies for tuberculosis treatment.
    Lancet. 2025 Mar 11:S0140-6736(25)00199-0. doi: 10.1016/S0140-6736(25)00199.
    PubMed    
    
    
    
11. TRAJMAN A, Campbell JR, Kunor T, Ruslami R, et al
    Tuberculosis.
    Lancet. 2025;405:850-866.
    PubMed     Abstract available
    
    
    February 2025
12. ZUMLA A, Sahu S, Yeboah-Manu D, Goletti D, et al
    Breaking dependency: strengthening the global tuberculosis response in the face of USAID cuts.
    Lancet. 2025 Feb 26:S0140-6736(25)00335-6. doi: 10.1016/S0140-6736(25)00335.
    PubMed    
    
    
    October 2024
13. BHARGAVA A, Bhargava M, Velayutham B, Benedetti A, et al
    Nutritional supplementation for tuberculosis prevention: the RATIONS trial - Authors' reply.
    Lancet. 2024;404:1524.
    PubMed    
    
    
    
14. ZHANG K, Xu Y, Hu Y, Chen X, et al
    Nutritional supplementation for tuberculosis prevention: the RATIONS trial.
    Lancet. 2024;404:1523-1524.
    PubMed    
    
    
    
15. BUSANG J, Khan P
    Nutritional supplementation for tuberculosis prevention: the RATIONS trial.
    Lancet. 2024;404:1522-1523.
    PubMed    
    
    
    
16. RICKMAN HM, Yates TA
    Nutritional supplementation for tuberculosis prevention: the RATIONS trial.
    Lancet. 2024;404:1522.
    PubMed    
    
    
    
17. KAUR JABINDA M
    Nutritional supplementation for tuberculosis prevention: the RATIONS trial.
    Lancet. 2024;404:1521-1522.
    PubMed    
    
    
    
18. BHATTARAI MD
    Utilising available isoniazid-resistance tests in new patients.
    Lancet. 2024;404:1403.
    PubMed    
    
    
    August 2024
19. KIZITO S, Nabayinda J, Nabunya P, Ssewamala FM, et al
    HIV and tuberculosis in Uganda: are we neglecting poverty?
    Lancet. 2024;404:844-845.
    PubMed    
    
    
    June 2024
20. HYDE L
    Mobile screening for Ukraine's wartime tuberculosis epidemic.
    Lancet. 2024;403:2771.
    PubMed    
    
    
    March 2024
21. BURKI T
    Pivotal tuberculosis vaccine trial begins.
    Lancet. 2024;403:1125.
    PubMed    
    
    
    
22. BHARGAVA A, Bhargava M, Pai M
    Tuberculosis: a biosocial problem that requires biosocial solutions.
    Lancet. 2024 Mar 20:S0140-6736(24)00489-6. doi: 10.1016/S0140-6736(24)00489.
    PubMed    
    
    
    
23. SUBBARAMAN R, Fielding K
    Putting technology to the test in tuberculosis care.
    Lancet. 2024;403:878-879.
    PubMed    
    
    
    January 2024
24. WEI X, Hicks JP, Zhang Z, Haldane V, et al
    Effectiveness of a comprehensive package based on electronic medication monitors at improving treatment outcomes among tuberculosis patients in Tibet: a multicentre randomised controlled trial.
    Lancet. 2024 Jan 31:S0140-6736(23)02270-5. doi: 10.1016/S0140-6736(23)02270.
    PubMed     Abstract available
    
    
    November 2023
25. SAMARASEKERA U
    Anurag and Madhavi Bhargava: enhancing TB prevention and care.
    Lancet. 2023;402:1740.
    PubMed    
    
    
    October 2023
26. BURKI T
    J&J patent decision to enable generic tuberculosis treatment.
    Lancet. 2023;402:1313.
    PubMed    
    
    
    September 2023
27. THE LANCET
    Tuberculosis: a different way of doing things.
    Lancet. 2023;402:937.
    PubMed    
    
    
    
28. REID M, Agbassi YJP, Arinaminpathy N, Bercasio A, et al
    Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis.
    Lancet. 2023 Sep 13:S0140-6736(23)01379-X. doi: 10.1016/S0140-6736(23)01379.
    PubMed    
    
    
    
29. BEKO B, Furin J
    Beyond individual inclusion, investment in affected communities is needed to end tuberculosis.
    Lancet. 2023 Sep 13:S0140-6736(23)01892-5. doi: 10.1016/S0140-6736(23)01892.
    PubMed    
    
    
    August 2023
30. BHARGAVA A, Bhargava M, Meher A, Benedetti A, et al
    Nutritional supplementation to prevent tuberculosis incidence in household contacts of patients with pulmonary tuberculosis in India (RATIONS): a field-based, open-label, cluster-randomised, controlled trial.
    Lancet. 2023 Aug 8:S0140-6736(23)01231-X. doi: 10.1016/S0140-6736(23)01231.
    PubMed     Abstract available
    
    
    
31. SINHA P, Mehta S
    Food: the tuberculosis vaccine we already have.
    Lancet. 2023 Aug 8:S0140-6736(23)01321-1. doi: 10.1016/S0140-6736(23)01321.
    PubMed    
    
    
    April 2023
32. REID M, Yamey G, Goosby E, Jamison D, et al
    Seizing opportunities to end TB: a call for ambition and optimism on World TB Day.
    Lancet. 2023;401:1153.
    PubMed    
    
    
    March 2023
33. KIRBY T
    Ruvandhi Nathavitharana: advancing TB diagnostics and advocacy.
    Lancet. 2023;401:990.
    PubMed    
    
    
    
34. KASAEVA T, Dias HM, Pai M
    Fast-tracking progress to End TB: high-level opportunities for investment and action.
    Lancet. 2023;401:975-978.
    PubMed    
    
    
    
35. WATTS G
    Bern-Thomas Nyang'wa: getting things done in TB and HIV.
    Lancet. 2023 Mar 17:S0140-6736(23)00576-7. doi: 10.1016/S0140-6736(23)00576.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge.